Stay updated on Flutiform K-haler Clinical Trial
Sign up to get notified when there's something new on the Flutiform K-haler Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FYj805A10p218WmMQMODYESUCNCc.uncropped.jpg&w=3840&q=75)
Latest updates to the Flutiform K-haler Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.5%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more Show more Revision: v2.9.0' has recently changed to 'Show less MedlinePlus related topics: Asthma FDA Drug and Device Resources Show less Design Details Primary Purpose : Treatment Allocation : N/A Interventional Model : Single Group Assignment Masking : None (Open Label) Arms and Interventions Participant Group/Arm Intervention/Treatment Experimental : Brand Name: Flutiform K-haler Brand Name: Flutiform K-haler Generic name: Fluticasone/formoterol dosage form: oral inhalation Drug : Brand Name: Flutiform K-haler Brand Name: Flutiform K-haler Generic name: Fluticasone/formoterol dosage form: oral inhalation Other Names: Flutiform K-haler Primary Outcome Measures Outcome Measure Measure Description Time Frame The primary endpoint of the study is the change in Asthma control test from baseline to Week 12 on treatment change in Asthma control test from baseline to Week 12 on treatment Week 0, Week 12 Additional Relevant MeSH Terms Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Asthma Studies a U.S. FDA-Regulated Drug Product No Studies a U.S. FDA-Regulated Device Product No Revision: v2.9.1.' This change represents an update in the study details and primary outcome measures of the clinical trial related to Flutiform K-haler in asthma patients.SummaryDifference10%
Stay in the know with updates to Flutiform K-haler Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flutiform K-haler Clinical Trial page.